The Drug Enforcement Administration last week published an interim final rule expanding access to medication-assisted treatment under the SUPPORT for Patients and Communities Act of 2018.

Effective Oct. 30, the rule allows certain practitioners to treat more patients; permanently adds nurse practitioners and physician assistants to the definition of “qualifying other practitioner”; and permits practitioners to complete required opioid training in medical school or residency as well as post-residency.

DEA will accept comments on the rule through Jan. 4.

DEA also will accept comments through Jan. 4 on a proposed rule implementing requirements to report suspicious orders of controlled substances under the Preventing Drug Diversion Act of 2018. The rule would offer multiple options for reporting suspicious orders; establish a centralized database for reporting; define key terms; and require specific record-keeping practices.

Related News Articles

Headline
The House June 4 passed the AHA-supported SUPPORT Act (H.R. 2483) by a 366-57 vote. The legislation reauthorizes key prevention, treatment and recovery…
Headline
Sens. Chuck Schumer, D-N.Y., Susan Collins, R-Maine, and Andy Kim, D-N.J., June 5 reintroduced the SEPSIS Act, legislation which would task the Centers for…
Blog
Even before the COVID pandemic, the mental health and wellness of our young people was failing. The pandemic exacerbated the crisis and made it difficult for…
Perspective
Public
After approval in the House last week by a one vote margin, the One Big Beautiful Bill Act — a sweeping package that would enact many of President Trump’s…
Headline
A new AHA video highlights how Corewell Health is transforming youth behavioral health care access in rural Michigan through school-based clinics and…
Headline
AHA May 23 submitted recommendations to the Department of Justice and Federal Trade Commission in response to the agencies’ requests for information on…